Seragon Biosciences, a research-based biopharmaceutical company, has developed an innovative aging intervention candidate named SRN-901.
SRN-901 recently underwent a comprehensive preclinical study, yielding highly impressive results.
Study Results:
The study, conducted on mice, found that SRN-901:
- Increased the remaining lifespan by one-third in middle-aged mice.
- Significantly improved several healthspan parameters and metabolic markers.
- Positively affected genes associated with longevity, while reducing the activity of genes linked to aging.
- Improved metabolic markers associated with a younger biological age.
Elaboration on Molecular and Cellular Effects:
This study of SRN-901 showed one of the largest extensions of lifespan and healthspan observed to date in the treated population.
To understand how SRN-901 works at the molecular level, researchers sequenced the transcriptome of over 300 mice.
This sequencing allows examination of all mRNA molecules in a cell, representing active genes.
The results revealed a significant increase in the expression of many genes related to longevity, alongside a notable decrease in the expression of genes linked to aging.
Additionally, metabolic analysis showed positive changes in several biomarkers indicating a younger biological age.
Significant Improvement in Overall Health:
Beyond extending lifespan, additional tests were conducted to assess the impact of SRN-901 on healthspan, which measures the period during which a person or animal maintains good health.
The study also examined physical and cognitive functions.
Running tests on a treadmill showed a marked improvement in the endurance of older mice that received SRN-901.
Their frailty scores also improved significantly, meaning their overall health improved notably.
Moreover, a significant reduction in the occurrence of tumors was observed in the treatment group.
Next Steps:
The research team at Seragon Biosciences is very optimistic about the study results.
They will conduct additional analyses to uncover further findings.
Once the supplementary analyses are complete, the full results will be published.
Importance of the Study:
This study represents a significant advancement in the field of aging and longevity.
If SRN-901 proves effective in humans, it could change how we approach aging and age-related diseases.
It may have a substantial impact on people's health and lifespan in the future.
References:
💬 Comments (0)
Be the first to comment on the article.